{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:25:34Z","timestamp":1783005934266,"version":"3.54.5"},"reference-count":46,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CSG\u2010P30CA134274"],"award-info":[{"award-number":["CSG\u2010P30CA134274"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Poor blood pressure control and low adherence to antihypertensives increase the risk for anthracycline\u2010induced cardiotoxicity (AIC) in hypertensive cancer patients. Little is known about whether past adherence to antihypertensive medications can reduce the risk of AIC in patients initiating anthracyclines. We examined adherence to antihypertensives pre\u2010anthracycline initiation and its association with the risk of AIC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study using a 25% random sample of IQVIA PharMetrics Plus for Academics US health plan claims, 2006\u20132022. We identified individuals 18\u2013 64\u2009years old, with hypertension, diagnosed with breast cancer or lymphoma (Hodgkin's or Non\u2010Hodgkin's) 9\u2009months before the anthracycline treatment initiation (index date). Group\u2010based trajectory modeling was used to estimate latent subgroups of antihypertensive adherence before the index date, using monthly proportions of days covered over the 9\u2009months (baseline). Using Cox regression models, we examined the risk of AIC in the 12\u2009months after the index date.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified four distinct antihypertensive adherence trajectory groups in the baseline period. In the adjusted model, the risk of AIC was higher in the early decline group (hazard ratio [HR]\u2009=\u20091.67, 95% CI [1.11\u20132.49]) and the moderate adherence (HR\u2009=\u20091.62, 95% CI [1.16\u20132.26]) groups compared to the near\u2010perfect adherence group. Comorbidities associated with an increased risk of AIC include diabetes and chronic kidney failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Poor adherence to antihypertensives prior to anthracycline use was associated with AIC. Future studies should explore whether select antihypertensive classes are more cardioprotective than others.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/pds.70318","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:26:01Z","timestamp":1768879561000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antihypertensive Past Adherence Trajectories and Risk of Cardiotoxicity Among Adults Initiating Anthracycline Treatment"],"prefix":"10.1002","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8829-2652","authenticated-orcid":false,"given":"Udim","family":"Damachi","sequence":"first","affiliation":[{"name":"Department of Practice, Sciences, and Health Outcomes Research University of Maryland School of Pharmacy  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberechukwu","family":"Onukwugha","sequence":"additional","affiliation":[{"name":"Department of Practice, Sciences, and Health Outcomes Research University of Maryland School of Pharmacy  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu Murali","family":"Mysore","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine University of Maryland School of Medicine  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1336-8106","authenticated-orcid":false,"given":"Wendy","family":"Camelo Castillo","sequence":"additional","affiliation":[{"name":"Department of Practice, Sciences, and Health Outcomes Research University of Maryland School of Pharmacy  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.1273"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26230"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.5603\/CJ.a2020.0062"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.312395"},{"key":"e_1_2_10_6_1","unstructured":"National Cancer Institute Division of Cancer Prevention Cardiotoxicity. Accessed October 14 2023(2023) https:\/\/prevention.cancer.gov\/major\u2010programs\/supportive\u2010care\u2010and\u2010symptom\u2010management\/topic\u2010areas\/cardiotoxicity."},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.54669"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2023.100760"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1920"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcrp.2022.200153"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_100015"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103153441101"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.20.2441"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hco.0000126978.03828.9e"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2021.01.005"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2013.85"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.011742"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549\u2010016\u20104043\u20101"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.029362"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12911\u2010015\u20100155\u20105"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1159\/000360229"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S270809"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2023.12.008"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/0962280216673085"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.clinpsy.121208.131413"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2012.2578"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2340"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14512"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac244"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2023.131219"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2022.03.006"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.312156"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.789"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/80.3.557"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4917"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018403"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10081647"},{"issue":"3","key":"e_1_2_10_38_1","first-page":"263","article-title":"Hypertension in Cancer Patients","volume":"38","author":"Mouhayar E.","year":"2011","journal-title":"Texas Heart Institute Journal"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.5888\/pcd14.160512"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2017.48"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000187261.40190.2e"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S457026"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.12495"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.07.031"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2018.24.11.1146"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S313874"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs317"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.70318","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pds.70318","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.70318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T01:11:38Z","timestamp":1773191498000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.70318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1002\/pds.70318"],"URL":"https:\/\/doi.org\/10.1002\/pds.70318","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"2025-05-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70318"}}